Literature DB >> 6282190

The in vitro activity, human pharmacology, and clinical effectiveness of new beta-lactam antibiotics.

H C Neu.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6282190     DOI: 10.1146/annurev.pa.22.040182.003123

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


× No keyword cloud information.
  19 in total

1.  Ceftriaxone and Cefotaxime Have Similar Effects on the Intestinal Microbiota in Human Volunteers Treated by Standard-Dose Regimens.

Authors:  Charles Burdet; Nathalie Grall; Morgane Linard; Antoine Bridier-Nahmias; Michèle Benhayoun; Khadija Bourabha; Mélanie Magnan; Olivier Clermont; Camille d'Humières; Olivier Tenaillon; Erick Denamur; Laurent Massias; Sarah Tubiana; Loubna Alavoine; Antoine Andremont; France Mentré; Xavier Duval
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

Review 2.  Pharmacological properties of cephalosporins.

Authors:  W Christ
Journal:  Infection       Date:  1991       Impact factor: 3.553

3.  Bile levels of imipenem in patients with T-drain following the administration of imipenem/cilastatin.

Authors:  M Mayer; C Tophof; W Opferkuch
Journal:  Infection       Date:  1988 Jul-Aug       Impact factor: 3.553

Review 4.  Pharmacokinetic properties of the cephalosporins.

Authors:  T Bergan
Journal:  Drugs       Date:  1987       Impact factor: 9.546

5.  Cefsulodin sodium therapy in cystic fibrosis patients.

Authors:  I Cabezudo; R L Thompson; R F Selden; S H Guenthner; R P Wenzel
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

Review 6.  Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  D M Richards; R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-06       Impact factor: 9.546

7.  Production of hypoprothrombinemia by moxalactam and 1-methyl-5-thiotetrazole in rats.

Authors:  J J Lipsky; J C Lewis; W J Novick
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

8.  Coagulopathy associated with extended-spectrum cephalosporins in patients with serious infections.

Authors:  R L Nichols; M A Wikler; J T McDevitt; A L Lentnek; J A Hosutt
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

9.  Chemotherapeutic properties of the new cephalosporin antibiotic HR810 in laboratory animals.

Authors:  N Klesel; M Limbert; E Schrinner; K Seeger; G Seibert; I Winkler
Journal:  Infection       Date:  1984 Jul-Aug       Impact factor: 3.553

10.  In vitro antibacterial activity and beta-lactamase stability of E-0702, a new cephalosporin.

Authors:  H C Neu; P Labthavikul
Journal:  Antimicrob Agents Chemother       Date:  1983-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.